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In this study the regulation of the release of noradrenaline
by P2 receptors was investigated in hippocampus slices
preincubated with [3H]NA. Electrical field stimulation
(EFS; 2 Hz, 240 shock, 1 ms) enhanced the release of
noradrenaline in a [Ca]o-dependent manner. In contrast,
the excess release in response to ischemic-like conditions
(combined oxygen and glucose deprivation) was [Ca]o-
independent. The Na+ channel blocker tetrodotoxin (1–3
μM) abolished both EFS-evoked and in vitro ischemia-
evoked release of tritium. The P2 receptor agonists ATP,
ADP and 2-MeSADP concentration-dependently
decreased the tritium overflow with the potency order of
ADP > 2-MeSADP > ATP. The inhibition by ATP (300 μM)
was prevented by the P2 receptor antagonist PPADS (30
μM), by the P2Y1 receptor antagonist MRS2179 (10 μM)
and by the P2Y12/13 receptor antagonist 2-MeSAMP (10μM). Under ischemic-like conditions the P2X1 receptor
antagonist PPNDS (1 μM) inhibited the outflow of
[3H]NA, whereas MRS2179 (10 μM) significantly
increased the tritium outflow. PPADS and 2-MeSAMP did
not affect ischemia-evoked [3H]NA efflux. RT-PCR analy-
sis revealed that mRNA encoding P2Y12 and P2Y13 recep-
tor subunits were expressed in the brainstem including
locus coeruleus. The pharmacological profile of the
underlying receptor subtype resembles the P2Y1 and
P2Y13 receptor phenotype, and the endogenous activation
of P2X1 and P2Y1 receptors contribute to the modulation
of noradrenaline efflux upon ischemic-like conditions.
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